**Trader consensus heavily favors "No" at 90% implied probability because official surveillance from WHO, CDC, and ECDC shows no novel pathogen with sustained human-to-human transmission capable of triggering a pandemic before 2028.** Global respiratory virus activity remains low, with regional variations only. The Bundibugyo Ebola outbreak in the DRC—declared a PHEIC in May 2026 with over 9,500 cases and 4,600 deaths—has seen limited cross-border spread to Kenya and Nigeria but lacks the efficient airborne transmission needed for pandemic scale. H5N1 avian influenza continues sporadic zoonotic cases tied to animal exposure, with no sustained human chains and explicitly unchanged low pandemic risk per WHO assessments. Measles and dengue surges are vaccine-preventable or regionally contained. Upcoming model runs and case surveillance through late 2026 offer the next key data points, though current conditions support the market's caution against near-term escalation.